Possible online services disruption due to Internet related outage
Drugs and Therapeutics (D & T) Committee Meeting Results for: March 19, 2014 (revised April 7, 2014)
Drug Name | Review Type | Committee Recommendation | Prior Approval Status � Final Determination |
---|---|---|---|
Sovaldi | New Drug Initial Review | Require Prior Approval | Prior Approval Required |
Otrexup | New Drug Initial Review | Require Prior Approval | Prior Approval Required |
Brintellix | New Drug Initial Review | Require Prior Approval | Prior Approval Required |
Olysio | New Drug Initial Review | Require Prior Approval | Prior Approval Required |
Natroba | New Drug Appeal | Require Prior Approval | Prior Approval Required |
Quillivant XR | New Drug Appeal | Remove Prior Approval Requirement | Prior Approval Required |
Linzess | New Drug Appeal | Remove Prior Approval Requirement | Prior Approval Required |
TOBI Podhaler | New Drug Appeal | Remove Prior Approval Requirement | Prior Approval Required |
Abilify Maintena | PDL Appeal | Add to Preferred Status | Preferred and Require Prior Approval |
Onglyza | PDL Appeal | Require Prior Approval | Prior Approval Required |